Screener
SAB Biotherapeutics SABS Q2 2025 earnings
Reported August 7, 2025 · Before market open
EPS-$1.09Miss by $0.27
Revenue estimate$83.3K
EPS estimate-$0.82
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$125.0K
EPS estimate-$0.27
Versus estimates
Diluted EPS
FAQ
- When did SAB Biotherapeutics report Q2 2025 earnings?
- SAB Biotherapeutics (SABS) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were SAB Biotherapeutics's Q2 2025 revenue and EPS?
- SAB Biotherapeutics reported eps of $-1.09 for Q2 2025.
- Did SAB Biotherapeutics beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.82 by $0.27.
- How did SAB Biotherapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 38.0% from $-0.79.
- Where can I find SAB Biotherapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-104566) directly on SEC EDGAR. The filing index links above go to sec.gov.
